PharmaResearch Co., Ltd. Logo

PharmaResearch Co., Ltd.

Develops regenerative medicine, devices & cosmetics using marine biotechnology.

214450 | KO

Overview

Corporate Details

ISIN(s):
KR7214450009
LEI:
Country:
South Korea
Address:
강원도 강릉시 과학단지로 77-19, 강릉시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

PharmaResearch Co., Ltd. is a biopharmaceutical company specializing in regenerative medicine. It develops, produces, and sells a range of products including pharmaceuticals, medical devices, and cosmetics. The company's core technology leverages marine biotechnology to create refined raw materials for cell and tissue regeneration. In addition to its product lines, PharmaResearch also offers consulting services for the development, licensing, and registration of medical products. The company is dedicated to enhancing human health through its innovative regenerative solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-21 00:00
Regulatory News Service
불성실공시법인미지정 (지정유예)
Korean 5.5 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 4.3 MB
2025-08-08 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 17.7 KB
2025-08-01 00:00
Report Publication Announcement
결산실적공시예고
Korean 4.0 KB
2025-07-31 00:00
Regulatory News Service
불성실공시법인지정예고 (공시번복)
Korean 4.9 KB
2025-07-08 00:00
M&A Activity
기타주요경영사항 (회사분할결정 철회)
Korean 3.4 KB
2025-07-08 00:00
M&A Activity
[기재정정]주요사항보고서(회사분할결정)
Korean 27.3 KB
2025-07-08 00:00
Report Publication Announcement
[기재정정]기업설명회(IR)개최
Korean 9.8 KB
2025-06-27 00:00
Environmental & Social Information
지속가능경영보고서등관련사항(자율공시)
Korean 13.9 KB
2025-06-27 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 9.0 KB
2025-06-20 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 8.9 KB
2025-06-18 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 9.0 KB
2025-06-16 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 8.9 KB
2025-06-13 00:00
Delisting Announcement
주권매매거래정지 (분할)
Korean 4.9 KB
2025-06-13 00:00
M&A Activity
주요사항보고서(회사분할결정)
Korean 49.2 KB

Automate Your Workflow. Get a real-time feed of all PharmaResearch Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for PharmaResearch Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for PharmaResearch Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

REGENXBIO Inc. Logo
Developing AAV gene therapies for retinal, metabolic, and neurodegenerative diseases.
United States of America
RGNX
Rein Therapeutics, Inc. Logo
Clinical-stage biopharma developing novel therapies for orphan pulmonary diseases and fibrosis.
United States of America
RNTX
Rekah Pharmaceutical Prod Ltd. Logo
A full-service generic pharma manufacturer of drugs, devices, and supplements for global markets.
Israel
REKA
Relay Therapeutics, Inc. Logo
Developing precision medicines for oncology & genetic diseases by analyzing protein motion.
United States of America
RLAY
Repare Therapeutics Inc. Logo
Develops precision oncology drugs using a CRISPR platform for cancers with genomic instabilities.
United States of America
RPTX
Replek AD Logo
Manufactures & distributes generic medicines, supplements, and cosmetic products to over 25 countries.
North Macedonia
REPL
Respiratorius AB Logo
Develops oncology pre-treatment drugs to enhance the efficacy of standard cancer therapies.
Sweden
RESP
REVELATION BIOSCIENCES, INC. Logo
Develops therapies that reprogram the innate immune system to reduce inflammation-related damage.
United States of America
REVB
REVIVA PHARMACEUTICALS HOLDINGS, INC. Logo
Clinical-stage biopharma developing novel therapies for CNS, respiratory, and metabolic diseases.
United States of America
RVPH
Revolution Medicines, Inc. Logo
A clinical-stage oncology company developing targeted therapies for RAS-addicted cancers.
United States of America
RVMD

Talk to a Data Expert

Have a question? We'll get back to you promptly.